Balyasny Asset Management’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-87,200
Closed -$730K – 2683
2023
Q2
$730K Sell
87,200
-153,900
-64% -$1.6M ﹤0.01% 1742
2023
Q1
$3.05M Buy
241,100
+57,500
+31% +$665K 0.01% 1281
2022
Q4
$1.67M Buy
183,600
+63,900
+53% +$690K ﹤0.01% 1482
2022
Q3
$1.41M Sell
119,700
-35,900
-23% -$454K ﹤0.01% 1667
2022
Q2
$2M Buy
+155,600
New +$2.08M 0.01% 1395

Other funds holding SKIN

Balyasny Asset Management's SKIN Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in SkinHealth Systems (SKIN) in Q2 2026: 22,794 shares worth $15.8K. The stake represents ﹤0.01% of the portfolio and ranks #2930 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in SKIN as recently as Q2 2023.

Balyasny Asset Management first reported a position in SKIN in Q3 2021 and has held it in 6 quarters since. The position peaked at $11.2M in Q3 2021. 97 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Balyasny Asset Management held 22,794 shares of SkinHealth Systems worth $15.8K as of Q2 2026.
  • SkinHealth Systems was a new Balyasny Asset Management position in Q2 2026.
  • SkinHealth Systems made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2930 holding.
  • Balyasny Asset Management first reported a position in SkinHealth Systems in Q3 2021 and has held it in 6 quarters since.
  • Balyasny Asset Management's SkinHealth Systems position peaked at $11.2M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.